iSpecimen effectuates 1-for-40 reverse stock split to regain Nasdaq compliance

iSpecimen Inc.

Reverse stock split effective 4:30 p.m. ET on April 27, 2026; trading on split-adjusted basis began April 28.
Shares outstanding reduced from 52,639,796 to approximately 1,316,032; no fractional shares issued (rounded up).
Board also ratified prior 1:20 reverse split (Sept 2024) via Certificate of Validation under Delaware law.
CUSIP changed to 45032V306; symbol remains ISPC on Nasdaq Capital Market.
Split intended to increase per-share price to attract institutional investors and meet minimum bid listing requirement.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

iSpecimen Inc.: Fifth Amended and Restated Certificate of Incorporation filed to effect 1-for-40 reverse stock split and ratify prior 1:20 reverse stock split (effective 2026-04-29).

Change: charter amendment
Effective: 2026-04-29

Exact text from the filing

On April 29, 2026, iSpecimen Inc. (the “Company”) filed a Fifth Amended and Restated Certificate of Incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware, which, among other things, effectuated a reverse stock split of the Company’s issued and outstanding shares of common stock, par value $0.0001 per share, at a ratio of 1-for-40 (the “Reverse Stock Split”).

View on SEC.gov

86 governance changes filed in the last 30 days. Browse all governance changes →

iSpecimen Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-051013

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.